Tall cell carcinoma with reverse polarity of breast: report of a case with unique morphologic and molecular features
Open Access
- 1 January 2020
- journal article
- research article
- Published by Federation of Turkish Pathology Societies in Turkish Journal of Pathology
- Vol. 37 (2) , 183-188
Abstract
Breast carcinomas are a heterogeneous group of malignancy, having variable clinical outcomes depending on their cellular and molecular properties. Tall cell carcinoma with reverse polarity (TCCRP) is a recently described rare entity, which shares morphological features with tall cell variant of papillary thyroid carcinoma but has a distinct morphological, immunohistochemical, and molecular profile. We describe a case of a 40-year-old female patient, who presented with lump in the breast. The patient underwent lumpectomy and was diagnosed as tall cell carcinoma with reverse polarity. Immunohistochemistry and bi-directional Sanger sequencing for IDH2 mutation were used for diagnosis. Tall cell carcinoma with reverse polarity is a rare and newly described entity with characteristic morphological and molecular findings, which carries an excellent prognosis.Keywords
This publication has 12 references indexed in Scilit:
- Breast Tumours Resembling the Tall Cell Variant of Thyroid Papillary Carcinoma: Are They Part of the Papillary Carcinoma Spectrum or a Distinct Entity?Pathobiology, 2018
- Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional casesLaboratory Investigation, 2018
- Solid Papillary Breast Carcinomas Resembling the Tall Cell Variant of Papillary Thyroid NeoplasmsAmerican Journal of Surgical Pathology, 2017
- Breast Tumor Resembling Tall Cell Variant of Papillary Thyroid CarcinomaAmerican Journal of Clinical Pathology, 2017
- Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypesBMC Cancer, 2014
- IDH1 and IDH2 Mutations in GliomasCurrent Neurology and Neuroscience Reports, 2013
- Frequent Mutation of Isocitrate Dehydrogenase(IDH)1andIDH2in Cholangiocarcinoma Identified Through Broad-Based Tumor GenotypingThe Oncologist, 2011
- The prognostic significance of IDH2 mutations in AML depends on the location of the mutationBlood, 2011
- IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumoursThe Journal of Pathology, 2011
- Breast Tumor Resembling the Tall Cell Variant of Papillary Thyroid CarcinomaAmerican Journal of Surgical Pathology, 2003